Valuation: Isodiol International Inc

Market Cap 39.11L 27.43L 24.51L 22.86L 20.77L 27Cr 39.41L 2.75Cr 1.07Cr 13Cr 1.03Cr 1.01Cr 43Cr P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 91.33L 64.05L 57.23L 53.39L 48.5L 62Cr 92.02L 6.42Cr 2.51Cr 32Cr 2.4Cr 2.35Cr 101.29Cr EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Manager TitleAgeSince
Chief Executive Officer - 24/05/2017
Corporate Officer/Principal - 30/08/2018
Director TitleAgeSince
Director/Board Member - 24/05/2017
Director/Board Member - 30/08/2018
Director/Board Member - 21/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
-90.63%+880.01% - - 128
+2.70%+2.73%+40.91%+107.91% 1,03200Cr
+1.44%-2.38%+36.83%+63.02% 61TCr
+1.75%+3.73%+16.55%+81.99% 47TCr
+0.60%-1.73%+62.98%+36.64% 35TCr
+2.92%+3.06%+24.83%+45.10% 34TCr
+2.42%-0.74%+13.44%+35.80% 27TCr
+1.86%-0.81%-4.69%+12.20% 25TCr
+2.60%-2.00%+39.77%+52.12% 22TCr
+1.82%-1.48%+25.75%+95.64% 18TCr
Average -7.44%-3.39%+28.48%+58.94% 41.28TCr
Weighted average by Cap. +1.98%-3.18%+31.96%+69.38%

Financials

2018 2019
Net sales 1.91Cr 1.34Cr 1.2Cr 1.12Cr 1.02Cr 129.82Cr 1.93Cr 13Cr 5.25Cr 66Cr 5.04Cr 4.93Cr 212.24Cr 2.22Cr 1.56Cr 1.39Cr 1.3Cr 1.18Cr 150.92Cr 2.24Cr 16Cr 6.11Cr 77Cr 5.86Cr 5.73Cr 246.74Cr
Net income -3.6Cr -2.53Cr -2.26Cr -2.11Cr -1.91Cr -244.35Cr -3.63Cr -25Cr -9.89Cr -124.27Cr -9.48Cr -9.28Cr -399.48Cr -13Cr -8.83Cr -7.89Cr -7.36Cr -6.69Cr -854.12Cr -13Cr -88Cr -35Cr -434.38Cr -33Cr -32Cr -1.4TCr
Net Debt -1.55Cr -1.09Cr -97.43L -90.9L -82.56L -105.48Cr -1.57Cr -11Cr -4.27Cr -54Cr -4.09Cr -4.01Cr -172.45Cr 52.22L 36.62L 32.72L 30.53L 27.73L 35Cr 52.61L 3.67Cr 1.43Cr 18Cr 1.37Cr 1.35Cr 58Cr
Logo Isodiol International Inc
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-